http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#Head http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#assertion http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#provenance http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#pubInfo http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#assertion https://uts.nlm.nih.gov/uts/umls/concept/C0026336 http://wordnet-rdf.princeton.edu/lemma/integrate https://uts.nlm.nih.gov/uts/umls/concept/C0011777 http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#provenance http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#assertion http://www.w3.org/ns/prov#generatedAtTime 2021-12-16T19:30:07.951579 http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC project version 2 http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#version http://www.w3.org/ns/prov#value 2 http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT http://www.w3.org/2000/01/rdf-schema#label into the final PK / PD model, ", where dexamethasone ( DEX ) exerted dexamethasone ( DEX ) s antitumor efficacy by inhibiting the proliferation of tumor cells", enhanced dexamethasone ( DEX ) responses by decreasing the sensitivity parameter EC(50 ) http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label 38 http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE http://www.w3.org/2000/01/rdf-schema#label integrated http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION http://www.w3.org/2000/01/rdf-schema#label [154] http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT http://www.w3.org/2000/01/rdf-schema#label The PK model of dopamine D(2)-like receptor ( D2DR ) antagonist sulpiride ( SUL ) as well as that of dexamethasone ( DEX ) with a time-dependent clearance http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label 6 http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:wdxnfuun&rows=50 wdxnfuun http://www.w3.org/2000/01/rdf-schema#SENTENCE http://www.w3.org/2000/01/rdf-schema#label The PK model of dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) as well as that of dexamethasone (DEX) with a time-dependent clearance were integrated into the final PK/PD model both using Hill’s function, where dexamethasone (DEX) exerted dexamethasone (DEX)'s antitumor efficacy by inhibiting the proliferation of tumor cells, and dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) enhanced dexamethasone (DEX) responses by decreasing the sensitivity parameter EC(50). http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:wdxnfuun-TRIPLE-ABSTRACT-10 wdxnfuun-TRIPLE-ABSTRACT-10 https://uts.nlm.nih.gov/uts/umls/concept/C0011777 http://www.w3.org/2000/01/rdf-schema#label dexamethasone https://uts.nlm.nih.gov/uts/umls/concept/C0026336 http://www.w3.org/2000/01/rdf-schema#label model http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#pubInfo http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#assertion http://www.w3.org/ns/prov#wasDerivedFrom https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470835/ http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#sig http://purl.org/nanopub/x/hasSignature fuOBBpRexYJsdSpV+S6ACSKp6DkIKPgwIEP9bZRPZTKEIBuPbrdHYa5k6UjrmvwkpwkHw+CrKvWIwo636XAFk+S2gmdmUt8AZpgN0B7i4hK+9TPKGFFvmGAvz54cEJvYah0mBD3kLPuvsbe4RQq3QFpmU5scGcHChkrTVWNv/Lo= http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI http://www.w3.org/ns/prov#generatedAtTime 2021-12-16T19:30:07.951579 http://purl.org/np/RAralS_DaSsjbk_eoVpXyL7vqlNgty2Zm_oJL9Ad19llI http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-8954-0470